Sanofi says U.S. regulators reject MS treatment Lemtrada

PARIS (Reuters) - Sanofi said its Lemtrada multiple sclerosis treatment failed to win approval from U.S. regulators to launch in the world's biggest drug market.

via Reuters: Health News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/12/sanofi-says-us-regulators-reject-ms.html